10-15% of pancreatic cancer are due to a predisposition syndrome towards hereditary cancer. Given the high mortality associated with this disease, identifying patients at risk for developing pancreatic cancer is essential to establish follow-up programs that lead to early detection of this disease. In the presence of exocrine pancreatic cancer, our recommendation would be to study the following genes.
1) Download & fill out
Please cover as many fields as possible in both documents
2) Sample collection
See sample types in the guidelines
3) Pack the sample
Please pack the sample in a way to prevent leakage
4) Send the sample & the request
Please schedule the delivery for Monday–Friday: 8am – 5pm
5) Result: the report
Via: e-mail and/or through the customer portal
"*" indicates required fields
Turnaround time (TAT): 15 days
Ref. S-202211931
Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.
